The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

During a 10-year follow-up, metformin use was associated with significantly lower risks for both dementia and all-cause mortality in patients with overweight or obesity. Metformin, the most widely ...

Metformin, the world’s most widely used diabetes drug, has long been recognized for its surprising range of benefits beyond lowering blood sugar, from reducing inflammation to lowering cancer risk.